EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A comprehensive review on the medicinally valuable endosymbiotic fungi Penicillium chrysogenum

Rawan Shaaban, Mohamed S Elnaggar, Noha Khalil, Abdel Nasser B Singab

Archives of Microbiology · 2023-06 · 205 (6)

DOI: 10.1007/s00203-023-03580-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Microbiology, online erschienen am 17.05.2023. Verfasst von Rawan Shaaban und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Future University in Egypt, Cairo, 11835, Egypt. Hauptthemen laut MEDLINE: Penicillium chrysogenum, Anti-Infective Agents, Penicillium. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ain Shams University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, it has been shown that metabolites derived from endosymbiotic fungi attracted high attention, since plenty of them have promising pharmaceutical applications. The variation of metabolic pathways in fungi is considered an optimistic source for lead compounds. Among these classes are terpenoids, alkaloids, polyketides, and steroids, which have proved several pharmacological activities, including antitumor, antimicrobial, anti-inflammatory, and antiviral actions. This review concludes the major isolated compounds from different strains of Penicillium chrysogenum during the period 2013–2023, together with their reported pharmacological activities. From literature surveys, 277 compounds have been identified from P. chrysogenum, which has been isolated as an endosymbiotic fungus from different host organisms, with specific attention paid to those showing marked biological activities that could be useful in the pharmaceutical industry in the future. This review represents documentation for a valuable reference for promising pharmaceutical applications or further needed studies on P. chrysogenum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Penicillium chrysogenumAnti-Infective AgentsPenicilliumFungiAntiviral AgentsMetabolic Networks and PathwaysPharmaceutical Preparations

Stichwörter der Autor:innen

AntimicrobialCytotoxicityEndosymbiotic fungusPenicillium chrysogenumSecondary metabolites

Substanzen

Anti-Infective AgentsAntiviral AgentsPharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Future University in Egypt, Cairo, 11835, Egypt.
  • Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo, 11566, Egypt.
  • Center of Drug Discovery Research and Development, Ain-Shams University, Cairo, 11566, Egypt.
  • Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo, 11566, Egypt. dean@pharma.asu.edu.eg.
  • Center of Drug Discovery Research and Development, Ain-Shams University, Cairo, 11566, Egypt. dean@pharma.asu.edu.eg.

Förderung

  • Ain Shams University

Zitieren

APA

Shaaban, R., Elnaggar, M. S., Khalil, N., & Singab, A. N. B. (2023). A comprehensive review on the medicinally valuable endosymbiotic fungi Penicillium chrysogenum. Archives of Microbiology, 205(6). https://doi.org/10.1007/s00203-023-03580-2

Vancouver

Shaaban R, Elnaggar MS, Khalil N, Singab ANB. A comprehensive review on the medicinally valuable endosymbiotic fungi Penicillium chrysogenum. Archives of Microbiology. 2023;205(6). doi:10.1007/s00203-023-03580-2

BibTeX
@article{Shaaban2023,
  author = {Shaaban, Rawan and Elnaggar, Mohamed S and Khalil, Noha and Singab, Abdel Nasser B},
  title = {A comprehensive review on the medicinally valuable endosymbiotic fungi Penicillium chrysogenum},
  journal = {Archives of Microbiology},
  year = {2023},
  volume = {205},
  number = {6},
  doi = {10.1007/s00203-023-03580-2}
}
Kostenlos starten →